| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Mai―27 |
Medical science and the madness of crowds; context for our COVID pandemic years |
Peter Rhodes |
| 2 |
[GO] |
2026―Mai―19 |
Batch-dependent safety signal: Nationwide analysis of suspected adverse events following COVID-19 vaccination in Germany |
Vibeke Manniche, Vít Karásek, Max Schmeling, Jonathan D. Gilthorpe, Tomáš Fürst, Peter Riis Hansen |
| 3 |
[GO] |
2026―Apr―24 |
Excess mortality, statistical significance, and causation: Analyzing controversies in COVID-19 vaccine research |
Raphael Lataster |
| 4 |
[GO] |
2026―Feb―14 |
The causes of Australian excess deaths in 2021, and beyond: An ecological study considering COVID-19, the lockdowns, and the vaccines |
Raphael Lataster |
| 5 |
[GO] |
2025―Nov―23 |
Why national consumption of direct oral anticoagulants over the rise of COVID-19 pandemic exceeded all potential recommendations: A qualitative analysis of textual details of Russian clinical practice guidelines |
Elena A. Baybulatova, Mikhail S. Chenkurov, Sergey K. Zyryanov, Liliya E. Ziganshina |
| 6 |
[GO] |
2025―Nov―01 |
Rectal shedding of SARS-CoV-2 in patients with negative COVID-19 nasopharyngeal RT-PCR test |
Svetlana Doris Brincat, Matthew Sammut, Neville Spiteri, Graziella Zahra, Christopher Barbara, Victor Grech, et al. (+2) Jo-Etienne Abela, Charles Cini |
| 7 |
[GO] |
2025―Sep―09 |
An analysis of Russian-produced clinical practice guidelines using the RIGHT reporting checklist: The case of direct oral anticoagulants for coronavirus disease 2019 |
Elena A. Baybulatova, Mikhail S. Chenkurov, Elina A. Korovyakova, Sergey K. Zyryanov, Dmitry A. Sychev, Irina V. Poddubnaya, et al. (+3) Yaolong Chen, Janne Estill, Liliya E. Ziganshina |
| 8 |
[GO] |
2025―Sep―09 |
Author’s response: Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic |
Vibeke Manniche, Tomáš Fürst, Max Schmeling, Jonathan D. Gilthorpe, Peter Riis Hansen |
| 9 |
[GO] |
2025―Sep―09 |
Comment on “Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic” |
Chiaki Suda |
| 10 |
[GO] |
2025―Jul―31 |
Population-level COVID-19 mortality trends |
Michael Gdalevich |
| 11 |
[GO] |
2025―Jul―21 |
REPLY TO COMMENT on “Population-Level COVID-19 Mortality Trends” |
Emmanuel O. Okoro, Nehemiah A. Ikoba, Boluwatife E. Okoro, Azibanigha S. Akpila, Mumeen O. Salihu |
| 12 |
[GO] |
2025―Jun―19 |
Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic |
Vibeke Manniche, Tomáš Fürst, Max Schmeling, Jonathan D Gilthorpe, Peter Riis Hansen |
| 13 |
[GO] |
2025―Apr―23 |
Paradoxical increase in global COVID-19 deaths with vaccination coverage: World Health Organization estimates (2020-2023) |
Emmanuel O Okoro, Nehemiah A Ikoba, Boluwatife E Okoro, Azibanigha S Akpila, Mumeen O Salihu |
| 14 |
[GO] |
2023―Jun―20 |
Impact of the COVID-19 pandemic on dispensing medicines in the community pharmacy |
Shafq Al-Azzawi, Dhafir Masheta |
| 15 |
[GO] |
2023―Mai―05 |
Workplace policies and quality of working life (QoWL) during the COVID-19 pandemic in Jordanian hospitals |
Mohammad S. Alyahya, Salam Momani, Main Naser Alolayyan, Yousef S. Khader |
| 16 |
[GO] |
2023―Mai―05 |
Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system |
Lisajo Orogun, Te-yuan Chyou, Prasad S. Nishtala |
| 17 |
[GO] |
2023―Mai―05 |
Healthcare-acquired Sars-Cov-2 infection: A viable legal category? |
Vittorio Bolcato, Livio Pietro Tronconi, Anna Odone, Lorenzo Blandi |
| 18 |
[GO] |
2022―Nov―22 |
Patient safety culture in a COVID-19 ICU compared to a clinical-surgical ICU in the Brazilian Eastern Amazon: A cross-sectional study |
Maria Luiza Rodrigues dos Santos, Victória Brioso Tavares, Natália Silva da Costa, Marcos Valério Santos da Silva, João Simão de Melo-Neto |
| 19 |
[GO] |
2022―Jul―26 |
Patients’ perception of personal protective equipment during the SARS-Cov-2 pandemic |
Aly Zaheer Pathan, Jennifer Barwell, Artemis Kastrissianakis, Kiran Awan, Anie Abila, Amelia Lim, et al. (+4) Rucchira Wickramasinghe, Anuj Pathare, Susan Deakin, Michael Okocha |
| 20 |
[GO] |
2022―Jul―22 |
Lessons learned from the COVID-19 pandemic: Improving initial investigations with the implementation of a COVID-19 blood request panel |
Lavandan Jegatheeswaran, Byung Choi, Martin Cohn, Amal Minocha, Ernest Mutengesa, Ashik Zala, et al. (+2) Michel Alhilani, Michael Okocha |
| 21 |
[GO] |
2022―Jul―01 |
Approach to the management of COVID-19 patients: When home care can represent the best practice |
Gerardo Tricarico, Valter Travagli |
| 22 |
[GO] |
2022―Apr―22 |
Response to “An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 23 |
[GO] |
2022―Mrz―15 |
Global pandemic vaccine development, production and distribution challenges for the world population |
Rade Injac, Vlasta Sikimić, Mike Stuart, Jamie Shaw |
| 24 |
[GO] |
2022―Mrz―11 |
Science funding policy and the COVID-19 pandemic |
Vlasta Sikimić, Mike Stuart, Jamie Shaw, Vlasta Sikimić, Mike Stuart, Jamie Shaw |
| 25 |
[GO] |
2022―Mrz―11 |
The social organization of science during the COVID-19 pandemic |
Manuela Fernández Pinto, Vlasta Sikimić, Mike Stuart, Jamie Shaw |
| 26 |
[GO] |
2022―Feb―22 |
Predicaments during a period of health emergency: Waiving patent protections or innovative public procurement? The example of advance purchase agreements (APA) for COVID-19 vaccines |
Nuria Garrido Cuenca, Carlo Bottari |
| 27 |
[GO] |
2022―Feb―11 |
Obesity and immune system impairment: A global problem during the COVID-19 pandemic |
Rosa Manca, Francisco Bombillar, Chester Glomski, Alessandra Pica, Carlo Bottari |
| 28 |
[GO] |
2022―Feb―11 |
EU health co-design policies to counteract the covid-19 pandemic effect promoting physical activity |
Luca Zambelli, Francesco Pegreffi, Carlo Bottari |
| 29 |
[GO] |
2021―Okt―29 |
Social distance capacity to control the COVID-19 pandemic: A systematic review on time series analysis |
Omid Khosravizadeh, Bahman Ahadinezhad, Aisa Maleki, Zahra Najafpour, Rohollah Golmohammadi |
| 30 |
[GO] |
2021―Aug―20 |
An old entity, a new trigger: Post COVID-19 vaccine Pityriasis rubra pilaris |
Mukesh Kumar Sahni, Kanika Roy, Dinesh Prasad Asati, Ujjawal Khurana |
| 31 |
[GO] |
2021―Feb―12 |
Healthcare risk management during the SARS-CoV-2 virus pandemic in the European Union: The guaranteed access to medicines |
Silvia Enríquez-Fernández, Carlos del Castillo-Rodríguez |
| 32 |
[GO] |
2020―Dez―29 |
Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective |
Kavita Manchanda, Jasbir Singh, Ranjeev Bhagat, Ilmjot Kaur Tiwana, Harmanjit Singh |
| 33 |
[GO] |
2020―Nov―06 |
The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination |
I. Ralph Edwards, Marie Lindquist |
| 34 |
[GO] |
2020―Okt―06 |
Perspectives on COVID-19 |
Arthur Dunkley |
| 35 |
[GO] |
2020―Aug―25 |
COVID-19 and healthcare-associated infections |
Andrea Cioffi, Raffaella Rinaldi |
| 36 |
[GO] |
2020―Jul―31 |
Does COVID-19 teach us anything for our future? |
Ivor Ralph Edwards, Marie Lindquist |
| 37 |
[GO] |
2020―Jun―26 |
A risk balancing act - tourism competition using health leverage in the COVID-19 era |
Victor Grech, Peter Grech, Stephanie Fabri |
| 38 |
[GO] |
2020―Jun―19 |
Some reflections on organizational profiles in Italy in the time of COVID-19 |
Carlo Bottari |
| 39 |
[GO] |
2020―Mai―29 |
Risk of using hydroxychloroquine as a treatment of COVID-19 |
Lo’ai Alanagreh, Foad Alzoughool, Manar Atoum |
| 40 |
[GO] |
2020―Apr―17 |
Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19 |
Foad Alzoughool, Lo’ai Alanagreh |
| 41 |
[GO] |
2019―Dez―03 |
Pandemic influenza vaccines and neuraminidase inhibitors: Efficacy and side effects |
D. Bijl |
| 42 |
[GO] |
2019―Dez―03 |
The sponsored pandemic of the Mexican flu? |
D. Bijl, H. Schellekens |
| 43 |
[GO] |
2019―Dez―03 |
Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? |
Cécile Viboud, Lone Simonsen |
| 44 |
[GO] |
2019―Dez―03 |
Factors influencing uptake of influenza vaccine amongst healthcare workers in a regional center after the A(H1N1) 2009 pandemic: Lessons for improving vaccination rates |
Mohamed Rida Tagajdid, Hicham El Annaz, Bouchra Belefquih, Taoufik Doblali, Jean Sébastien Casalegno, Yahia Mekki, Saâd Mrani |
